Current Assets 更改
AbbVie USD 38.87B 5.65B 2024-03
Acadia Pharmaceuticals USD 675.3M 59.17M 2024-03
ALKERMES USD 1.47B 37.69M 2024-03
Amgen USD 28.03B 2.3B 2024-03
Biogen USD 6.76B 103.1M 2024-03
BioMarin Pharmaceutical USD 2.99B 28.92M 2024-03
Bristol-Myers Squibb USD 28.67B 1.04B 2024-03
Eli Lilly USD 25.19B 2.18B 2024-03
Gilead Sciences USD 14.04B 2.41B 2024-03
Intra Cellular Therapies USD 690.53M 22.73M 2024-03
Ionis Pharmaceuticals USD 2.42B 226.18M 2024-03
J&J USD 57B 3.3B 2024-03
Malin Corporation EUR 35.8M 3M 2023-12
Merck USD 31.44B 509M 2024-03
Neurocrine Biosciences USD 1.8B 149.1M 2024-03
Otsuka Holdings JPY 1.31T 21.64B 2024-03
Pfizer USD 42.42B 31.6B 2024-03
Regeneron Pharmaceuticals USD 18.87B 5.62B 2024-03
Vertex Pharmaceuticals USD 13.29B 1.41B 2024-03



ALKERMES 流动资产 - 当前值,历史数据,预测,统计,图表和经济日历 - Jun 2024.